Estimating investment needed to optimally combat HIV, TB, and malaria
|
Continued investments in the fight against HIV,
tuberculosis, and malaria could result in enormous health gains and a high
return on investment, ... |
Nigeria : New HIV Drug May Exclude Vulnerable Populations
The recent approval of Yeztugo, a twice-yearly injectable medication for HIV prevention, has sparked global debate as health experts warn that its ... View article...